Phosphodiesterase type III inhibitor, cilostazol, inhibits colon cancer cell motility

By Murata Kohei   Kameyama Masao   Fukui Fumiyo   Ohigashi Hiroaki   Hiratsuka Masahiro   Sasaki Yo   Kabuto Toshiyuki   Mukai Mutsuko   Mammoto Tadanori   Akedo Hitoshi   Ishikawa Osamu   Imaoka Shingi  

Clinical and Experimental Metastasis, Vol. 17, Iss. 6, 1999-08 ,pp. : 525-530

Springer Publishing Company

Access to resources Recommend Favorite

The Role of Cell Motility in Prostate Cancer

By Banyard J.   Zetter B.R.  

Cancer and Metastasis Reviews, Vol. 17, Iss. 4, 1998-01 ,pp. : 449-458

Springer Publishing Company

Access to resources Recommend Favorite

Reduced expression of Snail decreases breast cancer cell motility by downregulating the expression and inhibiting the activity of RhoA GTPase

By                        

Oncology Letters, Vol. 6, Iss. 2, 2013-01 ,pp. : 339-346

Spandidos Publications

Access to resources Recommend Favorite

A review of the anti-tumor effect of the combined administration of a cyclooxygenase-2 selective inhibitor and a non-specific immunostimulant protein-bound polysaccharide on an advanced colon cancer model using colon cancer cell lines

By              

Oncology Letters, Vol. 2, Iss. 3, 2011-01 ,pp. : 509-514

Spandidos Publications

Access to resources Recommend Favorite

Inhibition of Pgp Activity and Cell Cycle-dependent Chemosensitivity to Doxorubicin in the Multidrug-resistant LoVo Human Colon Cancer Cell Line

By Toffoli G.   Corona G.   Gigante M.   Boiocchi M.  

European Journal of Cancer, Vol. 32, Iss. 9, 1996-08 ,pp. : 1591-1597

Elsevier

Access to resources Recommend Favorite